Stranded Technologies Podcast cover image

Ep. 99: A Conversation with Cremieux - How to Tell Good Science from Junk, and What’s Next in US Biotech & Deregulation

Stranded Technologies Podcast

00:00

Why FDA access to raw trial data matters

Cremieux explains how FDA reviewers see full datasets and why planned open data will expose reporting discrepancies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app